Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)

Sophia M. Orbach, Michael D. Brooks, Yining Zhang, Scott E. Campit, Grace G. Bushnell, Joseph T. Decker, Ryan J. Rebernick, Sriram Chandrasekaran, Max S. Wicha, Jacqueline S. Jeruss, Lonnie D. Shea

Research output: Contribution to journalComment/debatepeer-review

Abstract

Clinical & Experimental Metastasis (2022) 39:865–881 In the original publication of this article, the Acknowledgements section was published incorrectly. The correct Acknowledgements section is given in this correction. Acknowledgements Funds for this research were provided by the National Institutes of Health (NIH) R01 CA243916 (L.D.S and J.S.J.), NIH R01 CA214384 (L.D.S and J.S.J.), and NIH R35 CA197585 (M.S.W.). Further support was provided by the Dynami Foundation, the Breast Cancer Research Foundation (BCRF-18-173), and A Sister’s Hope. S.M.O is funded through the UM Postdoctoral Translational Scholar Program and NRSA F32 CA243421. S.E.C is a recipient of the Advanced Proteome Informatics of Cancer Training Program T32 CA140044. J.T.D. is funded through the NIH 5K01 EB028877. G.G.B is a recipient of the NRSA F31 CA224982. The original article has been corrected.

Original languageEnglish (US)
Pages (from-to)373
Number of pages1
JournalClinical and Experimental Metastasis
Volume40
Issue number4
DOIs
StatePublished - Aug 2023
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Single-cell RNA-sequencing identifies anti-cancer immune phenotypes in the early lung metastatic niche during breast cancer (Clinical & Experimental Metastasis, (2022), 39, 6, (865-881), 10.1007/s10585-022-10185-4)'. Together they form a unique fingerprint.

Cite this